Adage Capital Partners Gp, L.L.C. Connect Biopharma Holdings LTD Transaction History

Adage Capital Partners Gp, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.01 - $1.25 $381,294 - $471,898	-377,519 Reduced 36.74%	650,000 $734,000
Q4 2022 Feb 14, 2023	SELL	$0.64 - $1.31 $160,000 - $327,500	-250,000 Reduced 19.57%	1,027,519 $893,000
Q3 2022 Nov 14, 2022	SELL	$0.8 - $1.65 $320,000 - $660,000	-400,000 Reduced 23.84%	1,277,519 $1.65 Million
Q2 2022 Aug 15, 2022	BUY	$0.56 - $3.25 $134,410 - $780,061	240,019 Added 16.7%	1,677,519 $1.46 Million
Q1 2022 May 16, 2022	BUY	$2.46 - $5.92 $461,250 - $1.11 Million	187,500 Added 15.0%	1,437,500 $4.34 Million
Q4 2021 Feb 14, 2022	BUY	$4.26 - $23.33 $5.33 Million - $29.2 Million	1,250,000 New	1,250,000 $6.44 Million

3.28M

14K

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $45.7M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.